Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
aHR, 0.66
The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
When administered, semaglutide binds to GLP-1 receptors in the pancreas, stimulating insulin secretion in a glucose-dependent mannermeaning it only triggers insulin release when blood glucose levels are elevated
Purity tested Endotoxin tested Heavy metals tested A truncated kisspeptin neuropeptide that potently activates KISS1R, serving as a key regulator of the hypothalamic-pituitary-gonadal axis with applications in reproductive endocrinology research
You can expect long-lasting yet natural-looking fat reduction for the double chin area!
/media/img/mt/2026/07/PeptideGoldRush/original.png){kind=icon}
